Baseline characteristics of the eyes treated for AMD in 2008–2013 in Tays Eye Centre
| First treated eye (n=1117) | Second treated eye (n=232) | All eyes (n=1349) | ||||
| Age (years), median (IQR) | 80 | (74–84) | 81 | (77–85) | 80 | (75–84) |
| Female sex, n (%) | 765 | (68) | 179 | (77) | 944 | (70) |
| Baseline VA*, mean (SD) | 0.30 | (0.21) | 0.42 | (0.24) | 0.32 | (0.22) |
| Baseline VA*, n (%) | ||||||
| <0.3 | 589 | (53) | 72 | (31) | 661 | (49) |
| 0.3 – <0.5 | 297 | (27) | 75 | (32) | 372 | (28) |
| 0.5 – <0.8 | 197 | (18) | 62 | (27) | 259 | (19) |
| ≥0.8 | 32 | (3) | 21 | (9) | 53 | (4) |
| Missing | 2 | (0) | 2 | (1) | 4 | (0) |
*Snellen VA.
AMD, age-related macular degeneration; VA, visual acuity.